Literature DB >> 24274516

Mapping of low molecular weight heparins using reversed phase ion pair liquid chromatography-mass spectrometry.

Daoyuan Li1, Lequan Chi, Lan Jin, Xiaohui Xu, Xuzhao Du, Shengli Ji, Lianli Chi.   

Abstract

Low molecular weight heparins (LMWHs) are structurally complex, highly sulfated and negatively charged, linear carbohydrate polymers prepared by chemical or enzymatic depolymerization of heparin. They are widely used as anticoagulant drugs possessing better bioavailability, longer half-life, and lower side effects than heparin. Comprehensive structure characterization of LMWHs is important for drug quality assurance, generic drug application, and new drug research and development. However, fully characterization of all oligosaccharide chains in LMWHs is not feasible for current available analytical technologies due to their structure complexity and heterogeneity. Fingerprinting profiling is an efficient way for LMWHs' characterization and comparison. In this work, we present a simple, sensitive, and powerful analytical approach for structural characterization of LMWHs. Two different LMWHs, enoxaparin and nadroparin, were analyzed using reversed phase ion pair electrospray ionization mass spectrometry (RPIP-ESI-MS). More than 200 components were identified, including major structures, minor structures, and process related impurities. This approach is robust for high resolution and complementary fingerprinting analysis of LMWHs.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chain mapping; Low molecular weight heparin; Mass spectrometry; Reversed phase ion pair

Mesh:

Substances:

Year:  2013        PMID: 24274516     DOI: 10.1016/j.carbpol.2013.08.074

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  7 in total

1.  Analysis of Total Human Urinary Glycosaminoglycan Disaccharides by Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Xiaojun Sun; Lingyun Li; Katherine H Overdier; Lee Anne Ammons; Ivor S Douglas; Clay Cothren Burlew; Fuming Zhang; Eric P Schmidt; Lianli Chi; Robert J Linhardt
Journal:  Anal Chem       Date:  2015-06-02       Impact factor: 6.986

2.  Online Capillary Zone Electrophoresis Negative Electron Transfer Dissociation Tandem Mass Spectrometry of Glycosaminoglycan Mixtures.

Authors:  Morgan Stickney; Patience Sanderson; Franklin E Leach; Fuming Zhang; Robert J Linhardt; I Jonathan Amster
Journal:  Int J Mass Spectrom       Date:  2019-08-17       Impact factor: 1.986

3.  Analysis of heparin oligosaccharides by capillary electrophoresis-negative-ion electrospray ionization mass spectrometry.

Authors:  Lei Lin; Xinyue Liu; Fuming Zhang; Lianli Chi; I Jonathan Amster; Franklyn E Leach; Qiangwei Xia; Robert J Linhardt
Journal:  Anal Bioanal Chem       Date:  2016-06-20       Impact factor: 4.142

4.  Heparin/heparan sulfate analysis by covalently modified reverse polarity capillary zone electrophoresis-mass spectrometry.

Authors:  Patience Sanderson; Morgan Stickney; Franklin E Leach; Qiangwei Xia; Yanlei Yu; Fuming Zhang; Robert J Linhardt; I Jonathan Amster
Journal:  J Chromatogr A       Date:  2018-02-24       Impact factor: 4.759

5.  Bottom-up low molecular weight heparin analysis using liquid chromatography-Fourier transform mass spectrometry for extensive characterization.

Authors:  Guoyun Li; Julia Steppich; Zhenyu Wang; Yi Sun; Changhu Xue; Robert J Linhardt; Lingyun Li
Journal:  Anal Chem       Date:  2014-06-17       Impact factor: 6.986

6.  Commercial Low Molecular Weight Heparins - Patent Ecosystem and Technology Paradigm for Quality Characterization.

Authors:  Zarina Iqbal; Saima Sadaf
Journal:  J Pharm Innov       Date:  2022-07-28       Impact factor: 2.538

7.  GlycCompSoft: Software for Automated Comparison of Low Molecular Weight Heparins Using Top-Down LC/MS Data.

Authors:  Xiaohua Wang; Xinyue Liu; Lingyun Li; Fuming Zhang; Min Hu; Fuji Ren; Lianli Chi; Robert J Linhardt
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.